CELZ Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
-100.0%
3.0K
0
0
Cost of Revenue
0
0
-100.0%
994
0
0
Gross Profit
0
0
-100.0%
2.0K
0
0
Operating Expenses
1.6M
+7.1%
1.5M
-25.1%
1.9M
+53.0%
1.3M
+0.8%
1.3M
R&D
459.2K
-15.2%
541.7K
-1.5%
550.1K
+18.3%
465.2K
-7.2%
501.3K
SG&A
1.1M
+21.5%
888.6K
-35.0%
1.4M
+75.9%
776.8K
+6.2%
731.5K
Operating Income
-1562163
-7.1%
-1459153
+25.0%
-1945782
-52.8%
-1273034
-0.8%
-1263520
EBITDA
-1539245
-7.6%
-1430298
+25.3%
-1914833
-54.2%
-1241975
-0.7%
-1232778
Net Income
-1511250
-7.7%
-1403717
+25.6%
-1887674
-52.7%
-1235934
-0.2%
-1233303
EPS (Basic)
$-0.41
-7.9%
$-0.38
+51.9%
$-0.79
-64.6%
$-0.48
+0.0%
$-0.48
EPS (Diluted)
$-0.41
-7.9%
$-0.38
+51.9%
$-0.79
-64.6%
$-0.48
+0.0%
$-0.48
Shares (Diluted)
3.7M
+0.0%
3.7M
+54.9%
2.4M
-7.4%
2.6M
+0.0%
2.6M
Creative Medical Technology (CELZ) โ€” Financials